Delivery Order V797D50492-36C26124N0545
Award Date
3/27/24
Potential Completion Date
6/27/24
Potential Value
$64K
Federal Agency
Veterans Integrated Service Network 21
Ultimate Awardee
Takeda Pharmaceutical Company LIMITED
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lexington, MA 02421, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Takeda Pharmaceuticals America Inc., a subsidiary of Takeda Pharmaceutical Company LIMITED, a leading global biopharmaceutical company. The delivery order, valued at $129,841.55, is for the provision of CINRYZE C-1, a specialty pharmaceutical product, under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule contract. Takeda Pharmaceuticals America Inc. has an established...
This is a delivery order awarded to Takeda Pharmaceuticals America Inc., a subsidiary of Takeda Pharmaceutical Company LIMITED, against the General Services Administration (GSA) Pharmaceuticals and Drugs Schedule (FSS-61-IB) contract. The award is for the provision of CINRYZE, an emergency pharmaceutical product, to the Department of Veterans Affairs (VA). The delivery order has a ceiling value of $63,936.90 and a completion date of June 25, 2024. As a Firm Fixed Price contract, the order does...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed-price delivery order to Takeda Pharmaceuticals America Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The $36,890.40 order is for the specialty pharmaceutical product TAKHZYRO 150MG ML SYRINGE 2ML PER SYRINGE, which is used to treat hereditary angioedema. The delivery order has an April 2024 completion date and will support patient care programs across the VA's Veterans...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed-price delivery order to Takeda Pharmaceuticals America Inc., a subsidiary of Takeda Pharmaceutical Company LIMITED, for $22,375.80 to supply ADVATE vials. This order was placed against Takeda's Pharmaceuticals and Drugs GSA Schedule contract. Takeda Pharmaceuticals America Inc. is the prime contractor and has previously provided specialty pharmaceuticals, including treatments for hemophilia, immune...
The Department of Veterans Affairs Veterans Health Administration awarded Takeda Pharmaceuticals America Inc. a $36,101.68 firm fixed price delivery order for two packages of TAKHZYRO 150MG/ML prefilled syringes. Takeda Pharmaceuticals America Inc. will deliver the packages of the hereditary angioedema preventative medication to a location in Lexington, Massachusetts by November 1, 2023 to support VHA programs. The award was issued against Takeda Pharmaceutical Company Limited's...
The Department of Veterans Affairs Veterans Health Administration awarded Takeda Pharmaceuticals America Inc. a $36,101.68 firm fixed price delivery order against the company's GSA Schedule contract for Pharmaceuticals and Drugs. The delivery order is for TAKHZYRO 150MG/ML SYRINGE 2ML SYRINGE (2) to be supplied to Veterans Integrated Service Network 9, with performance taking place in Lexington, Massachusetts from September 6-7, 2023. As the prime contractor, Takeda Pharmaceuticals America...
The Department of Veterans Affairs Veterans Health Administration awarded Takeda Pharmaceuticals America Inc. a $36,101.68 firm fixed price delivery order for TAKHZYRO 150MG/ML syringes. Takeda Pharmaceuticals America Inc. will deliver the syringes to a location in Lexington, Massachusetts by September 21, 2023 to fulfill requirements under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), the parent vehicle held by Takeda Pharmaceutical Company LIMITED. The funding...
The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price delivery order to Takeda Pharmaceuticals America Inc., a subsidiary of the global pharmaceutical company Takeda Pharmaceutical Company Limited, for the supply of the specialty medication TAKHZYRO (lanadelumab-flyo) 150mg/2mL injection. The $215,511.40 contract is part of the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule 61-IB and will provide the critical treatment to VA medical facilities until...
This delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 awards Takeda Pharmaceuticals America Inc. a $36,890.40 firm fixed price contract to supply TAKHZYRO 150MG/ML SYRINGE 2ML PER SYRINGE with a quantity of 2. The contract is issued against Takeda Pharmaceuticals America Inc.'s existing Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), with performance taking place in Lexington, Massachusetts. No...
The U.S. Department of Veterans Affairs (VA) awarded a Firm Fixed Price Delivery Order for ADVATE vials to Takeda Pharmaceuticals America Inc. under its Pharmaceuticals and Drugs General Services Administration (GSA) Schedule contract. The $22,654.80 contract has an ultimate completion date of June 26, 2024. Takeda is a subsidiary of Takeda Pharmaceutical Company Limited, a leading global biopharmaceutical firm. Through this delivery order, the VA will procure the specialized pharmaceutical...